Esketamine Nasal Spray for the Rapid Reduction of Depressive Symptoms in Major Depressive Disorder With Acute Suicidal Ideation or Behavior

PURPOSE/BACKGROUND: Numerous health authority approvals of esketamine nasal spray, combined with oral antidepressant, to treat depressive symptoms in adults with major depressive disorder and acute suicidal ideation or behavior were based on 2 identically designed, double-blind, phase 3 studies. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Canuso, Carla M., Ionescu, Dawn F., Li, Xiang, Qiu, Xin, Lane, Rosanne, Turkoz, Ibrahim, Nash, Abigail I., Lopena, Tricia J., Fu, Dong-Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407443/
https://www.ncbi.nlm.nih.gov/pubmed/34412104
http://dx.doi.org/10.1097/JCP.0000000000001465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407443/
https://www.ncbi.nlm.nih.gov/pubmed/34412104
http://dx.doi.org/10.1097/JCP.0000000000001465

Ejemplares similares